Beranda › Penyakit Crohn › Wisconsin
Uji klinis Penyakit Crohn di Wisconsin
7 studi untuk Penyakit Crohn mencari peserta di lokasi di Wisconsin.
Kota di Wisconsin
Teks studi resmi (Bahasa Inggris)
Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight
- Wisconsin Center for Advanced Research, Milwaukee
Menerima pesertaFase 3
Usia 18 hingga 70 · Semua jenis kelamin · Diperbarui 24 Sep 2026 · NCT06937099An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
- Froedtert Hospital and the Medical College of Wisconsin-Site Number: 8400081, Milwaukee
Menerima pesertaFase 3
Usia 16 hingga 80 · Semua jenis kelamin · Diperbarui 23 Sep 2026 · NCT07184931Clinical, Imaging, and Endoscopic Outcomes of Children Newly Diagnosed With Crohn's Disease
- Medical College of Wisconsin, Milwaukee
Menerima pesertaFase 4
Usia 6 hingga 17 · Semua jenis kelamin · Diperbarui 27 Mei 2026 · NCT05781152A Study of Vedolizumab With and Without Upadacitinib in Adults With Crohn's Disease
- Medical College of Wisconsin Cancer Center - Froedtert Hospital, Milwaukee
Menerima pesertaFase 3
Usia 18 hingga 65 · Semua jenis kelamin · Diperbarui 27 Mei 2026 · NCT06227910Precise Infliximab Exposure and Pharmacodynamic Control
- Medical College of Wisconsin, Children's of Wisconsin, Milwaukee
Menerima pesertaFase 2/3
Usia 6 hingga 22 · Semua jenis kelamin · Diperbarui 5 Mei 2026 · NCT05660746A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease
- Mirador Therapeutics Selected Site, Milwaukee
Menerima pesertaFase 2
Usia 18 hingga 80 · Semua jenis kelamin · Diperbarui 12 Mar 2026 · NCT07113522Unhide® Project: A Digital Health Platform to Collect Lifestyle Data for Brain Inflammation Research
- Brain Inflammation Collaborative, Delafield
Menerima pesertaStudi observasionalSukarelawan sehat diterima
Usia 2 ke atas · Semua jenis kelamin · Diperbarui 22 Jan 2026 · NCT04806620Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.